局灶性18F-FDG-PET低代谢与癫痫手术结局的关联:系统综述与 Meta 分析
该系统综述与 Meta 分析纳入 98 项研究共 4104 例患者,评估术前 18F-FDG-PET 局灶性低代谢与癫痫手术良好结局的关联。结果显示,与切除区一致的局灶性低代谢与良好结局相关(OR 2.68,95% CI 2.08-3.45),且不受 MRI 致痫病灶是否存在影响;弥漫性低代谢则与更差结局相关(OR 0.34,95% CI 0.22-0.54)。作者认为这些发现支持将 18F-FDG-PET 纳入癫痫手术术前无创评估。
要点
- 与切除区一致的局灶性18F-FDG-PET低代谢与癫痫手术良好结局相关(OR 2.68,95% CI 2.08-3.45)。
- 无论MRI是否检出致痫病灶,局灶性低代谢均与良好结局相关(有病灶OR 2.64,无病灶OR 2.49)。
- 弥漫性低代谢较局灶性低代谢与更差手术结局相关(OR 0.34,95% CI 0.22-0.54)。
核心结论
- 局灶性18F-FDG-PET低代谢与癫痫手术良好结局相关,且不受MRI致痫病灶是否存在影响;低代谢范围提供额外信息,弥漫性低代谢较局灶性低代谢与更差手术结局相关。
- 这些发现支持将18F-FDG-PET纳入癫痫手术术前常规无创评估,以改善致痫区定位并辅助患者手术选择。
研究设计与样本
- 系统综述与Meta分析,检索数据库共识别8916项研究,最终纳入98项研究,总计4104例患者。
- 纳入标准为术前接受18F-FDG-PET评估、参与者≥10例、报告≥12个月手术结局的出版物。
- 采用随机效应Meta分析计算良好结局(Engel I级、国际抗癫痫联盟1-2级或无发作)的比值比,局灶性低代谢定义为与癫痫手术切除区一致。
- 采用Meta回归分析异质性来源。
主要发现
- 全部患者中,局灶性18F-FDG-PET低代谢与癫痫手术良好结局相关(OR 2.68,95% CI 2.08-3.45)。
- MRI检出致痫病灶者OR 2.64(95% CI 1.54-4.52),未检出致痫病灶者OR 2.49(95% CI 1.80-3.44)。
- 与EEG一致(OR 2.34,95% CI 1.43-3.83)、与MRI一致(OR 1.69,95% CI 1.19-2.40)、与两者三重一致(OR 2.20,95% CI 1.32-3.64)均与更高良好结局几率相关。
- 弥漫性18F-FDG-PET低代谢较局灶性低代谢与更差结局相关(OR 0.34,95% CI 0.22-0.54)。
关键数值与推荐
- 良好结局定义为Engel I级、国际抗癫痫联盟1-2级或无发作。
- 局灶性18F-FDG-PET低代谢定义为与癫痫手术切除区一致。
- 纳入研究需术前接受18F-FDG-PET评估、参与者≥10例、报告≥12个月手术结局。
临床怎么用
- 作者认为这些发现支持将18F-FDG-PET纳入癫痫手术术前常规无创评估,以改善致痫区定位并辅助患者手术选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although commonly used in the evaluation of patients for epilepsy surgery, the association between the detection of localizing 18fluorine fluorodeoxyglucose PET (18F-FDG-PET) hypometabolism and epilepsy surgery outcome is uncertain. We conducted a systematic review and meta-analysis to determine whether localizing 18F-FDG-PET hypometabolism is associated with favorable outcome after epilepsy surgery. METHODS: A systematic literature search was undertaken. Eligible publications included evaluation with 18F-FDG-PET before epilepsy surgery, with ≥10 participants, and those that reported surgical outcome at ≥12 months. Random-effects meta-analysis was used to calculate the odds of achieving a favorable outcome, defined as Engel class I, International League Against Epilepsy class 1-2, or seizure-free, with localizing 18F-FDG-PET hypometabolism, defined as concordant with the epilepsy surgery resection zone. Meta-regression was used to characterize sources of heterogeneity. RESULTS: The database search identified 8,916 studies, of which 98 were included (total patients n = 4,104). Localizing 18F-FDG-PET hypometabolism was associated with favorable outcome after epilepsy surgery for all patients with odds ratio (OR) 2.68 (95% CI 2.08-3.45). Subgroup analysis yielded similar findings for those with (OR 2.64, 95% CI 1.54-4.52) and without epileptogenic lesion detected on MRI (OR 2.49, 95% CI 1.80-3.44). Concordance with EEG (OR 2.34, 95% CI 1.43-3.83), MRI (OR 1.69, 95% CI 1.19-2.40), and triple concordance with both (OR 2.20, 95% CI 1.32-3.64) was associated with higher odds of favorable outcome. By contrast, diffuse 18F-FDG-PET hypometabolism was associated with worse outcomes compared with focal hypometabolism (OR 0.34, 95% CI 0.22-0.54). DISCUSSION: Localizing 18F-FDG-PET hypometabolism is associated with favorable outcome after epilepsy surgery, irrespective of the presence of an epileptogenic lesion on MRI. The extent of 18F-FDG-PET hypometabolism provides additional information, with diffuse hypometabolism associated with worse surgical outcome than focal 18F-FDG-PET hypometabolism. These findings support the incorporation of 18F-FDG-PET into routine noninvasive investigations for patients being evaluated for epilepsy surgery to improve epileptogenic zone localization and to aid patient selection for surgery.
引用
- Courtney MR, Antonic-Baker A, Chen Z, et al. Association of Localizing 18F-FDG-PET Hypometabolism and Outcome Following Epilepsy Surgery: Systematic Review and Meta-Analysis. Neurology. 2024. PMID: 38626375. doi:10.1212/WNL.0000000000209304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。